Aquatic Capital Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-89,651
Closed -$6.58M – 1540
2025
Q3
$6.58M Buy
+89,651
New +$5.96M 0.12% 207
2025
Q1
– Sell
-35,501
Closed -$1.7M – 1402
2024
Q4
$1.7M Buy
+35,501
New +$1.82M 0.05% 412
2024
Q3
– Sell
-16,900
Closed -$885K – 1305
2024
Q2
$885K Sell
16,900
-21,900
-56% -$960K 0.03% 419
2024
Q1
$1.58M Buy
38,800
+29,200
+304% +$1.09M 0.05% 296
2023
Q4
$355K Buy
+9,600
New +$362K 0.01% 720
2023
Q2
– Sell
-15,700
Closed -$600K – 1499
2023
Q1
$600K Buy
+15,700
New +$736K 0.04% 381
2022
Q3
– Sell
-6,700
Closed -$295K – 1330
2022
Q2
$295K Buy
+6,700
New +$290K 0.1% 254

Other funds holding HALO

Aquatic Capital Management's HALO Position: Q4 2025 in Review

Aquatic Capital Management sold out of Halozyme (HALO) in Q4 2025, closing a stake of 89,651 shares — an estimated $6.58M sold.

Aquatic Capital Management first reported a position in HALO in Q2 2022 and held it in 7 quarters. The position peaked at $6.58M in Q3 2025. 619 funds tracked by Wall St. Rank hold HALO as of Q4 2025.

  • Aquatic Capital Management reported no remaining Halozyme position as of Q4 2025 after selling out during the quarter.
  • Aquatic Capital Management sold 89,651 Halozyme shares in Q4 2025, an estimated $6.58M.
  • Aquatic Capital Management first reported a position in Halozyme in Q2 2022 and held it in 7 quarters.
  • Aquatic Capital Management's Halozyme position peaked at $6.58M in Q3 2025.
  • 619 funds tracked by Wall St. Rank held Halozyme as of Q4 2025.

Based on Aquatic Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.